Identification of Mad as a repressor of the human telomerase (hTERT) gene

Activation of telomerase, which has been frequently associated with cellular immortality, may constitute a key step in the development of human cancer. De-repression in the expression of its catalytic subunit hTERT gene has been proposed to directly link to the telomerase activation in tumor cells. Little is known about the mechanism how the hTERT gene is repressed in telomerase-negative mortal cells. This study was conducted, using an expression cloning approach, with the aim of identifying the gene(s) responsible for repressing the hTERT gene expression. Using this genetic screen, we isolated the transcription factor Mad as a repressor. Mutation of its DNA binding sites caused significant de-repression of hTERT promoter activity in mortal cells. This Mad-mediated repression of the hTERT promoter in mortal cells was counteracted by ectopic expression of Myc. The antagonism between Mad and Myc was also observed with an endogenous hTERT promoter. Their potential roles in differential hTERT promoter activities were further supported by the relative amounts of Mad and Myc proteins detected in immortal and mortal cells. Thus, Mad may be a direct negative regulator of hTERT in mortal cells and this repression mechanism can be inhibited by induction of Myc in immortal cells.

[1]  S. Lowe,et al.  Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.

[2]  C. Cooper,et al.  Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells. , 1999, Journal of the National Cancer Institute.

[3]  J. Shay,et al.  Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism? , 1995, Trends in cell biology.

[4]  M. Oshimura,et al.  Genetic Complementation of the Immortal Phenotype in Group D Cell Lines by Introduction of Chromosome 7 , 1995, Japanese journal of cancer research : Gann.

[5]  J. R. Smith,et al.  Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Chin,et al.  Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation , 1999, Oncogene.

[7]  J. Barrett,et al.  A gene involved in control of human cellular senescence on human chromosome 1q , 1994, Molecular and cellular biology.

[8]  U. Kim,et al.  In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells. , 1999, Biochemical and biophysical research communications.

[9]  R. Eisenman,et al.  Myc target genes. , 1997, Trends in biochemical sciences.

[10]  J. Shay,et al.  Multiple pathways for the regulation of telomerase activity. , 1997, European journal of cancer.

[11]  J. Yim,et al.  The Wilms' Tumor 1 Tumor Suppressor Gene Represses Transcription of the Human Telomerase Reverse Transcriptase Gene* , 1999, The Journal of Biological Chemistry.

[12]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[13]  Tom Maniatis,et al.  Regulation of Interferon-γ-Activated STAT1 by the Ubiquitin-Proteasome Pathway , 1996, Science.

[14]  R. Dalla‐Favera,et al.  Direct activation of TERT transcription by c-MYC , 1999, Nature Genetics.

[15]  M. Oshimura,et al.  Restoration of the Cellular Senescence Program and Repression of Telomerase by Human Chromosome 3 , 1995, Japanese journal of cancer research : Gann.

[16]  R. DePinho,et al.  Repression by the Mad(Mxi1)‐Sin3 complex , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  M. Oshimura,et al.  Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence , 1998, Molecular carcinogenesis.

[18]  J. Shay.  Toward identifying a cellular determinant of telomerase repression. , 1999, Journal of the National Cancer Institute.

[19]  R. Eisenman,et al.  Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity , 1993, Cell.

[20]  M. Cole,et al.  The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation , 1999, Oncogene.

[21]  R. Eisenman,et al.  Myc and Max associate in vivo. , 1992, Genes & development.

[22]  Chi V. Dang,et al.  c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism , 1999, Molecular and Cellular Biology.

[23]  V. Lundblad,et al.  The telomerase reverse transcriptase: components and regulation. , 1998, Genes & development.

[24]  R. Weinberg,et al.  hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization , 1997, Cell.

[25]  C B Harley,et al.  Telomerase catalytic subunit homologs from fission yeast and human. , 1997, Science.

[26]  D. Bowtell,et al.  Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. , 1997, Human molecular genetics.

[27]  S. Benchimol,et al.  Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span , 1998, Current Biology.